RT published this video item, entitled “Italy’s Lazio region seeks govt approval to manufacture Sputnik V vaccine” – below is their description.
Frustrated by the slow pace of the EU’s coronavirus inoculation program, Lazio is seeking permission to manufacture Russia’s Sputnik V vaccine. RT speaks to Alessio D’Amato, the regional health chief, about the approval process it will have to undergo.
Follow us on Telegram https://t.me/rtintl / https://t.me/rtvisual
RT YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: Sputnik V
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.
The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.
On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.